Procter & Gamble Health Limited (NSE: PGHL), ISIN INE199A01012 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
PGHL last traded at ₹6603.00 (-0.21%), with a 52-week range of ₹4699.70 to ₹6955.00 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 51.82%, FIIs 6.33%, DIIs 12.44%, mutual funds 9.05%.
EquiSense Score (ECS): 84/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.